Leticia Sánchez‐Reyes

657 total citations
24 papers, 505 citations indexed

About

Leticia Sánchez‐Reyes is a scholar working on Endocrinology, Diabetes and Metabolism, General Health Professions and Pharmacology. According to data from OpenAlex, Leticia Sánchez‐Reyes has authored 24 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 10 papers in General Health Professions and 7 papers in Pharmacology. Recurrent topics in Leticia Sánchez‐Reyes's work include Health and Lifestyle Studies (10 papers), Pharmacology and Obesity Treatment (6 papers) and Obesity, Physical Activity, Diet (5 papers). Leticia Sánchez‐Reyes is often cited by papers focused on Health and Lifestyle Studies (10 papers), Pharmacology and Obesity Treatment (6 papers) and Obesity, Physical Activity, Diet (5 papers). Leticia Sánchez‐Reyes collaborates with scholars based in Mexico, Honduras and Peru. Leticia Sánchez‐Reyes's co-authors include Guillermo Fanghänel, Arturo Berber, Luis Alcocer, J J Sienra-Monge, Blanca E. Del-Río-Navarro, J. Yamamoto, D. David Sisson, Vicenç Vallès, Ramón Alberto Rascón-Pacheco and Eva Torres and has published in prestigious journals such as Diabetes Care, International Journal of Obesity and Clinical Therapeutics.

In The Last Decade

Leticia Sánchez‐Reyes

24 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leticia Sánchez‐Reyes Mexico 13 233 180 160 145 90 24 505
Luca Montesi Italy 9 137 0.6× 164 0.9× 75 0.5× 98 0.7× 63 0.7× 12 500
Annie Ferland Canada 15 120 0.5× 177 1.0× 43 0.3× 120 0.8× 74 0.8× 30 487
Alessandra N. Faria Brazil 9 173 0.7× 243 1.4× 58 0.4× 162 1.1× 51 0.6× 12 645
Erika Paniago Guedes Brazil 11 100 0.4× 121 0.7× 92 0.6× 107 0.7× 25 0.3× 18 379
A. Albright United States 5 252 1.1× 229 1.3× 47 0.3× 77 0.5× 68 0.8× 7 587
Sujatro Chakladar United States 7 168 0.7× 204 1.1× 110 0.7× 63 0.4× 25 0.3× 18 546
Michelle Look United States 8 416 1.8× 327 1.8× 512 3.2× 150 1.0× 66 0.7× 12 879
Daniel Prud’homme Canada 3 157 0.7× 166 0.9× 26 0.2× 150 1.0× 33 0.4× 5 452
Fernando Flexa Ribeiro Filho Brazil 8 88 0.4× 181 1.0× 56 0.3× 93 0.6× 36 0.4× 9 378
Britt-Marie Ellsinger Netherlands 8 205 0.9× 185 1.0× 39 0.2× 242 1.7× 28 0.3× 8 544

Countries citing papers authored by Leticia Sánchez‐Reyes

Since Specialization
Citations

This map shows the geographic impact of Leticia Sánchez‐Reyes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leticia Sánchez‐Reyes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leticia Sánchez‐Reyes more than expected).

Fields of papers citing papers by Leticia Sánchez‐Reyes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leticia Sánchez‐Reyes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leticia Sánchez‐Reyes. The network helps show where Leticia Sánchez‐Reyes may publish in the future.

Co-authorship network of co-authors of Leticia Sánchez‐Reyes

This figure shows the co-authorship network connecting the top 25 collaborators of Leticia Sánchez‐Reyes. A scholar is included among the top collaborators of Leticia Sánchez‐Reyes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leticia Sánchez‐Reyes. Leticia Sánchez‐Reyes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gutiérrez-Salmeán, Gabriela, Virginia Corina Samaniego, Alejandra Meaney, et al.. (2015). OBESITY PHENOTYPES IN URBAN MIDDLE-CLASS COHORTS; THE PRIT-LINDAVISTA MERGING EVIDENCE IN MEXICO: THE OPUS PRIME STUDY.. PubMed. 32(1). 182–8. 12 indexed citations
2.
Sánchez‐Reyes, Leticia, et al.. (2013). Estatinas en adultos mayores, una población creciente. 56(1). 19–29. 2 indexed citations
3.
Fanghänel, Guillermo, et al.. (2011). Impacto de la disminución del perímetro de la cintura en el riesgo cardiovascular de pacientes obesos sujetos a tratamiento. Cirugía y Cirujanos. 79(2). 175–181. 10 indexed citations
4.
Sánchez‐Reyes, Leticia, et al.. (2011). [Multicenter international registry to evaluate the clinical practice delivered to patients with type 2 diabetes mellitus: a sub-analysis of the experience in Mexico].. PubMed. 147(3). 226–33. 6 indexed citations
5.
Fanghänel, Guillermo, et al.. (2011). Impact of waist circumference reduction on cardiovascular risk in treated obese subjects.. PubMed. 79(2). 175–81. 16 indexed citations
6.
Alcocer, Luis, et al.. (2011). Global cardiovascular risk stratification: comparison of the Framingham method with the SCORE method in the Mexican population.. PubMed. 79(2). 168–74. 15 indexed citations
7.
Villegas, Enrique, et al.. (2006). Efecto de las estatinas más allá del colesterol. 14(2). 73–88. 1 indexed citations
8.
Sánchez‐Reyes, Leticia, et al.. (2004). Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial. Clinical Therapeutics. 26(9). 1427–1435. 29 indexed citations
9.
Fanghänel, Guillermo, et al.. (2003). Safety and efficacy of sibutramine in overweight Hispanic patients with hypertension. Advances in Therapy. 20(2). 101–113. 21 indexed citations
10.
Del-Río-Navarro, Blanca E., et al.. (2003). The relationship between asthma symptoms and anthropometric markers of overweight in a Hispanic population.. PubMed. 13(2). 118–23. 35 indexed citations
11.
Fanghänel, Guillermo, et al.. (2001). Obesidad como factor de riesgo de cardiopatía coronaria en trabajadores del Hospital General de México. Estudio PRIT. 9(2). 51–59. 2 indexed citations
12.
Sánchez‐Reyes, Leticia, Arturo Berber, & Guillermo Fanghänel. (2001). Incidencia de obesidad en una población mexicana. 9(2). 60–66. 2 indexed citations
13.
Berber, Arturo, et al.. (2001). Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dyslipidaemia in a Mexican population. International Journal of Obesity. 25(12). 1794–1799. 111 indexed citations
14.
Fanghänel, Guillermo, et al.. (2001). Second phase of a double-blind study clinical trial on Sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-over. International Journal of Obesity. 25(5). 741–747. 30 indexed citations
15.
Fanghänel, Guillermo, et al.. (2001). Evolution of the Prevalence of Obesity in the Workers of a General Hospital in Mexico. Obesity Research. 9(4). 268–273. 14 indexed citations
16.
Fanghänel, Guillermo, et al.. (2000). A clinical trial of the use of Sibutramine for the treatment of patients suffering essential obesity. International Journal of Obesity. 24(2). 144–150. 79 indexed citations
17.
Sánchez‐Reyes, Leticia, et al.. (1998). [The prevalence of risk factors for coronary disease in workers of the Hospital General de México].. PubMed. 39(5). 427–32. 10 indexed citations
18.
Sánchez‐Reyes, Leticia, et al.. (1997). Prevalencia de factores de riesgo de enfermedad coronaria en trabajadores del Hospital General de México. Salud Pública de México. 39(5). 427–432. 17 indexed citations
19.
Sánchez‐Reyes, Leticia, et al.. (1997). Prevalence of risk factors of coronary disease in personnel of the General Hospital of Mexico. 39(5). 427–432. 10 indexed citations
20.
Fanghänel, Guillermo, et al.. (1996). Metformin's Effects on Glucose and Lipid Metabolism in Patients with Secondary Failure to Sulfonylureas. Diabetes Care. 19(11). 1185–1189. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luca Montesi Breakdown of academic impact, for papers by Annie Ferland Breakdown of academic impact, for papers by Alessandra N. Faria Breakdown of academic impact, for papers by Erika Paniago Guedes Breakdown of academic impact, for papers by A. Albright Breakdown of academic impact, for papers by Sujatro Chakladar Breakdown of academic impact, for papers by Michelle Look Breakdown of academic impact, for papers by Daniel Prud’homme Breakdown of academic impact, for papers by Fernando Flexa Ribeiro Filho Breakdown of academic impact, for papers by Britt-Marie Ellsinger
Rankless by CCL
2026